Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 735)
Posted On: 11/08/2022 8:48:33 PM
Post# of 154140
Posted By: ohm20
Re: Cassandra X #130282
Quote:
Therefore, wouldn't all of the "heat maps" of cytokines, if Leronlimab is able to do its job, look roughly identical?



350mg doesn't provide 100% blockade of CCR5 so you would find greater effect on the chemokines with 700mg so aggregated they wouldn't be identical. Individually they would vary greatly due to variation in disease severity or because of a myriad of genetic anomalies.

As compared to 350mg, the poor results on the heat map combined with the poor trial outcome lead me to believe that the factor involved is most likely varying CCR5 expression.













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site